Tag

Fresenius Medical Care

All articles tagged with #fresenius medical care

health1 year ago

Leading the Charge: Woman Behind World's Largest Dialysis Company

Helen Giza, CEO of Fresenius Medical Care, highlights the potential of new weight-loss drugs like Wegovy and Ozempic to extend the lives of chronic kidney disease patients. These drugs, known as GLP-1s, offer cardiovascular benefits that could delay the progression to end-stage renal disease. Fresenius is also launching an advanced dialysis machine in the US, which mimics natural kidney function and improves survival rates. Despite challenges like staff shortages and legal issues, Fresenius continues to innovate in dialysis and renal care globally.

business2 years ago

Ozempic's Kidney Trial Success Sends Dialysis Stocks Plummeting

Kidney-dialysis stocks, including Fresenius Medical Care and DaVita, experienced significant declines after Novo Nordisk announced that its diabetes drug Ozempic showed potential in delaying the progression of kidney disease. Frankfurt-listed shares in Fresenius Medical Care fell nearly 8%, while the company's American depositary receipts dropped 17%. Similarly, stock in U.S.-listed DaVita crashed 17%.

healthcare2 years ago

Ozempic's Success in Kidney Disease Trial Sends Dialysis Stocks Plummeting

Novo Nordisk's diabetes drug Ozempic has shown early effectiveness in treating kidney failure, according to an interim analysis of a study. The positive results have caused shares of major dialysis providers, including Fresenius Medical Care, Baxter International, and DaVita, to plummet. Ozempic, along with its sister drug Wegovy, has the potential to impact fields beyond diabetes and obesity, as recent studies have shown their effectiveness in reducing the risk of heart attacks and strokes. The trial's early termination suggests a faster effect than anticipated, and analysts believe that drugs like Ozempic could help reduce the number of kidney disease patients over time.

healthcare2 years ago

Fresenius Medical Care's Versi®HD with GuideMe Software Receives FDA Clearance

Fresenius Medical Care has received FDA clearance for Versi®HD with GuideMe Software, a self-guided interface for their VersiHD chronic home hemodialysis (HHD) system. The software aims to enhance the ease of use and confidence for both patients and nurses, improving patient training time and making the transition to home dialysis easier. The company is committed to providing cutting-edge solutions to improve the health and well-being of dialysis patients. VersiHD with GuideMe Software will be available in selected markets in 2023.